Literature DB >> 7826283

Immunohistochemical localization of fibrillin in human ocular tissues. Relevance to the Marfan syndrome.

H M Wheatley1, E I Traboulsi, B E Flowers, I H Maumenee, D Azar, R E Pyeritz, J A Whittum-Hudson.   

Abstract

OBJECTIVE: To better understand the ocular manifestations of the Marfan syndrome, we investigated the distribution of fibrillin in normal human ocular tissues. Fibrillin, a microfibrillar glycoprotein component of the extracellular matrix, has been found to be the defective gene product in the Marfan syndrome.
METHODS: Frozen sections from seven pairs of normal eyes were stained with mouse anti-human fibrillin antibodies using the avidin-biotin immunoperoxidase technique.
RESULTS: In the anterior segment, the following exhibited positive staining for fibrillin: the lens capsule and zonules; connective tissues of the iris, ciliary body, ciliary processes, and conjunctiva; and the basement membrane regions of the corneal epithelium and endothelium of Schlemm's canal. Posteriorly, fibrillin localized to the lamina cribrosa, sclera, choroid, and Bruch's membrane.
CONCLUSIONS: Fibrillin is widely distributed in ocular connective tissues. The implications of defects in these tissues and the resultant ocular abnormalities in the Marfan syndrome such as ectopia lentis and glaucoma are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7826283     DOI: 10.1001/archopht.1995.01100010105028

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  43 in total

1.  Fibrillin and the eye.

Authors:  J L Ashworth; C M Kielty; D McLeod
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

2.  The elastin fiber system between and adjacent to collector channels in the human juxtacanalicular tissue.

Authors:  Cheryl R Hann; Michael P Fautsch
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

Review 3.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

4.  An experimental study of the elastic properties of the human Bruch's membrane-choroid complex: relevance to ageing.

Authors:  M Ugarte; A A Hussain; J Marshall
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

5.  Elevated transforming growth factor β1 in plasma of primary open-angle glaucoma patients.

Authors:  John Kuchtey; Jessica Kunkel; L Goodwin Burgess; Megan B Parks; Milam A Brantley; Rachel W Kuchtey
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-24       Impact factor: 4.799

6.  ADAMTSL4, a secreted glycoprotein widely distributed in the eye, binds fibrillin-1 microfibrils and accelerates microfibril biogenesis.

Authors:  Luis A R Gabriel; Lauren W Wang; Hannah Bader; Jason C Ho; Alana K Majors; Joe G Hollyfield; Elias I Traboulsi; Suneel S Apte
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-31       Impact factor: 4.799

7.  Corneal Deformation Response and Ocular Geometry: A Noninvasive Diagnostic Strategy in Marfan Syndrome.

Authors:  Lauren C Beene; Elias I Traboulsi; Ibrahim Seven; Matthew R Ford; Abhijit Sinha Roy; Robert S Butler; William J Dupps
Journal:  Am J Ophthalmol       Date:  2015-10-24       Impact factor: 5.258

8.  Human eye development is characterized by coordinated expression of fibrillin isoforms.

Authors:  Dirk Hubmacher; Dieter P Reinhardt; Thomas Plesec; Katja Schenke-Layland; Suneel S Apte
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-18       Impact factor: 4.799

Review 9.  The microfibril hypothesis of glaucoma: implications for treatment of elevated intraocular pressure.

Authors:  John Kuchtey; Rachel W Kuchtey
Journal:  J Ocul Pharmacol Ther       Date:  2014-02-12       Impact factor: 2.671

10.  Candidate gene study to investigate the genetic determinants of normal variation in central corneal thickness.

Authors:  David P Dimasi; Kathryn P Burdon; Alex W Hewitt; Ravi Savarirayan; Paul R Healey; Paul Mitchell; David A Mackey; Jamie E Craig
Journal:  Mol Vis       Date:  2010-03-31       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.